Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
06/2004
06/17/2004US20040115714 Comprises nucleotide coding sequences associated with breast cancer cell-2 (BRCC-2) genes and proteins for use in the identification of modulators for prevention and treatment of tumors
06/17/2004US20040115713 Immobilized oligonucleotide sequences for detection and quantification of toxic inorganic materials, such as arsenic and metal compounds, using evanescent wave-employing device upon which a competitive binding surface is formed
06/17/2004US20040115712 for multiplex polymerase chain reactions (PCR) by the use of a volume excluding reagent in combination with a hot-start DNA polymerase; kits
06/17/2004US20040115711 Using variation in electrical charges and adjustments in surface tension to detect probe/biopolymer associations; nanostructures and micro-electro-mechanical systems
06/17/2004US20040115710 that does not utilize radioactive isotopes, does not require numerous washing steps, and can be performed in vitro, in vivo, in a cell based or isolated manner
06/17/2004US20040115709 Using multichanneled apparatus which utilizes electric, magnetic, enhanced gravitational and hydrodynamic forces to detect biological molecules, viruses and cells associated with immobilized surface probes
06/17/2004US20040115708 Using transient activation of stress-response pathways to identify modulators for treatment and prevention of cell proliferative, nervous system, autoimmune, inflammatory and cardiovascular disorders
06/17/2004US20040115706 by detecting a fluorescent signal; for drug screening; solid phase synthesis
06/17/2004US20040115705 Methods and systems for estimating the melting temperature (TM) for polynucleotide molecules
06/17/2004US20040115704 Identifying, evaluating and characterizing activity of transcriptional control elements using expression vectors and/or reporter vectors providing kinetics of protein expression; drug screening and discovery
06/17/2004US20040115702 Type 2 diabetes susceptibility genes
06/17/2004US20040115701 Characterizing and identifying genetic factors associated with epistatic disorders
06/17/2004US20040115700 Comprises nucleotide sequences coding transcriptional splice variants of hippocampal and mammary gland negative regulatory protein for use in diagnosis and treatment of alzheimer's disease
06/17/2004US20040115699 Single nucleotide polymorphisms diagnostic for schizophrenia
06/17/2004US20040115697 Detecting tumors disorders via identifying centrosomal aberrations in microtubule organizing center of cell
06/17/2004US20040115696 Utilizing programmable functionalized self-assembling nucleic acids as building blocks for molecular electronic and photonic mechanisms, organizing interconnected nanostructures and/or micronized components of micro or optoelectronic devices
06/17/2004US20040115695 Methods for generating enhanced antibody producing cell lines with improved growth characteristics
06/17/2004US20040115694 Methods and compositions for determining the sequence of nucleic acid molecules
06/17/2004US20040115693 Novel human kinase proteins and polynucleotides encoding the same
06/17/2004US20040115692 Detecting nucleic acids in methanol solution using fluorescein or lanthanide chelate
06/17/2004US20040115690 Method of detecting inflammatory lung disorders
06/17/2004US20040115689 Method and device for collecting and stabilizing a biological sample
06/17/2004US20040115688 Detection of gd2 synthase mrna and uses thereof
06/17/2004US20040115686 Materials and methods to detect alternative splicing of mrna
06/17/2004US20040115685 Immobilisation of ligands
06/17/2004US20040115684 Method for genotype determination
06/17/2004US20040115683 Analysis of gene expression and biological function using optical imaging
06/17/2004US20040115680 Biochemical method and apparatus for detecting genetic characteristic
06/17/2004US20040115678 Dna markers for meat tenderness
06/17/2004US20040115674 Suppression of non-specific nucleic acid amplication
06/17/2004US20040115672 Use of electrical fields to control interactions between proteins and nucleic acid constructions immobilized on solid supports
06/17/2004US20040115671 Using adjustments in transcription in vascular tissue to diagnose brain degenerative diseases associated with dysfunction of learning, memory, and/or cognition
06/17/2004US20040115666 Method for identifying compounds modulating reverse cholesterol transport
06/17/2004US20040115665 Method for base sequencing and biologically active nucleic acids
06/17/2004US20040115664 measuring an expression level or levels of a specific gene or genes in a tumor cell collected from a cancer patient treated with an anticancer agent
06/17/2004US20040115663 Method for the detection of cytosine methylations in immobilized dna samples
06/17/2004US20040115660 Method of diagnosising abnormalities by screening for tyrosine kinase like molecules or their signalling mediators
06/17/2004US20040115656 Androgen receptor down-regulatory-associated proteins(ARDAPs) for use in reduction of transactivation activity of androgen receptors and treatment of tumors; gene expression inhibition and anticarcinogenic agents
06/17/2004US20040115655 Determining nucleotide sequence of target fragment using primase to synthesize short DNA sequences and mass spectroscopy decipher nucleic acids
06/17/2004US20040115654 Preparing nucleotide sequence array platforms; genomics; genotyping
06/17/2004US20040115652 Antisense oligonucleotides for controlling expression of receptor tyrosine kinase gene and treatment of hyperproliferative disorders; gene expression inhibition
06/17/2004US20040115643 Replicating nucleotide sequences using limited primer/chain extension; genome characterization
06/17/2004US20040115641 Antisense oligonucleotides for controlling expression of rho-associated coiled-coil-containing protein kinase 1 (ROCK-1) and treatment of hyperproliferative disorders; gene expression inhibition
06/17/2004US20040115640 Modulation of angiopoietin-2 expression
06/17/2004US20040115639 first modified thermostable enzyme exhibiting 3'exonuclease activity but no DNA polymerase activity and a second modified thermostable enzyme exhibiting DNA polymerase activity; modifier reagent is cis-aconitic anhydride or citraconic anhydride
06/17/2004US20040115638 Modulation of tumor susceptibility gene 101 expression
06/17/2004US20040115636 Modulation of interleukin 18 expression
06/17/2004US20040115635 Modulation of PTPN13 expression
06/17/2004US20040115634 Antisense oligonucleotides for controlling expression of signal transducers and activators of transcription-6 (STAT-6) genes and treatment of autoimmune disorders; gene expression inhibition
06/17/2004US20040115633 Modulation of mitochondrial ribosome protein S16 expression
06/17/2004US20040115632 Methods and reaction mixture reagent for increasing the 3' end specificity of oligonucleotide priming
06/17/2004US20040115630 Comprises oligomeric peptide nucleic acid for identifying cytosine methylation state of genomic DNA and classifying, diagnosing and treating of brain tumors
06/17/2004US20040115629 Molecules for diagnostics and therapeutics
06/17/2004US20040115627 Genetically engineered cells comprising regulatory elements for use as tools in identifying compounds that alter protein expression: high throughput assay
06/17/2004US20040115625 Cancer gene determination and therapeutic screening using signature gene sets
06/17/2004US20040115623 Identifying cmpounds which dramatically reduce herpes viral replicative capacity; viricides; enzyme inhibitors
06/17/2004US20040115622 Mixture of peptides originating from a Nef protein and applications thereof
06/17/2004US20040115618 Method of quantification hiv-1rna-dna hybrid and diagnosis kit
06/17/2004US20040115617 Diagnosing viral food poisioning using genetically engineered viral RNA sequences
06/17/2004US20040115616 Stem-loop vector system
06/17/2004US20040115614 Measuring physiological response in cell via electric field stimulation
06/17/2004US20040115319 For detecting bacteria in a perishable food product
06/17/2004US20040115306 Prolyl-specific endoprotease is added to the beverage
06/17/2004US20040115130 Methods using O6 -alkyguanine-dna alkyltransferases
06/17/2004US20040115129 Nucleic acid sequence 1 or 3; amino acid sequence 2 or 4
06/17/2004US20040114780 Pixel arrays
06/17/2004US20040113077 Surface plasmon resonance systems and methods having a variable charge density layer
06/17/2004US20040112518 Polymer bonding by means of plasma activation
06/17/2004DE10255894A1 Detecting peroxide activity in cells or tissue, useful in e.g. histology or medicine, uses soluble styrene derivative as substrate to form a localized fluorescent reaction product
06/17/2004DE10255861A1 Preventing or treating hepatitis C virus infection comprises administering an agent that inhibits or stimulates the activity or production of human gastrointestinal glutathione peroxidase
06/17/2004DE10254703A1 Vorrichtung zur Bestimmung der Aktivität von Enzymen Apparatus for determining the activity of enzymes
06/17/2004DE10234577A1 Method for recombination of double-stranded DNA from different diversification strategies, useful e.g. for assembling synthetic genes, based on amplification with primers that create strand breaks
06/17/2004CA2549213A1 Concurrent microorganism identification and susceptibilities
06/17/2004CA2517566A1 Protein synthesis monitoring (psm)
06/17/2004CA2511829A1 Method for hybridisation of immobilized genomic dna
06/17/2004CA2508236A1 Ampk pathway components
06/17/2004CA2508212A1 Chemically amplified electrochemical detection of affinity reaction
06/17/2004CA2508052A1 Control of apoptosis using a complex of an oligonucleotide and a regulatory peptide
06/17/2004CA2507812A1 Predicting animal performance
06/17/2004CA2507761A1 Cancer associated plexinb1 mutations
06/17/2004CA2507455A1 Enzyme immobilization for use in biofuel cells and sensors
06/17/2004CA2507398A1 Monitoring high-risk environments
06/17/2004CA2507189A1 Fragmentation-based methods and systems for sequence variation detection and discovery
06/17/2004CA2507079A1 Method for universal detection of micro-organisms and reaction medium therefor
06/17/2004CA2507077A1 Methods and compositions for inducing apoptosis in cancer cells
06/17/2004CA2506748A1 Method for in vitro selection of 2'-substituted nucleic acids
06/17/2004CA2506727A1 Treatment of huntington's disease with epa
06/17/2004CA2506630A1 Heart failure gene determination and therapeutic screening
06/17/2004CA2488473A1 Use of fluorine nmr for high throughput screening
06/17/2004CA2453387A1 Compositions and methods related to nitrotyrosine-containing compounds as antigenic agents
06/16/2004EP1429274A2 Methods for sequence display and homology search
06/16/2004EP1429259A1 Biological sequence information reading method and storing method
06/16/2004EP1428892A1 Dual-purpose primers and probes for providing enhanced hybridization assays by disruption of secondary structure formation
06/16/2004EP1428891A1 Novel gene nedl-1
06/16/2004EP1428890A1 METHOD OF JUDGING MISMATCH BETWEEN SINGLE−STRANDED NUCLEIC ACID MOLECULES
06/16/2004EP1428889A1 Method for monitoring the transition of a cell from one state into another
06/16/2004EP1428882A1 Nucleic acids showing difference in expression between hepatoblastoma anc normal liver
06/16/2004EP1428880A1 Kidney-specific urate transporter and gene thereof
06/16/2004EP1428875A1 Method of diagnosis of obesity
06/16/2004EP1428810A2 Libraries of oligomers labelled with different tags